NCT04441151 Evaluation of the Effect of Pulmonary Rehabilitation on Patients With High Flow Oxygen Therapy
| NCT ID | NCT04441151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese PLA General Hospital |
| Condition | Pulmonary Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2025-03-20 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2025-03-20 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of the effect of pulmonary rehabilitation on patients with high flow oxygen therapy
Eligibility Criteria
Inclusion Criteria: * The age is ≥ 18 years old; * the hemodynamics is stable; * 50 \< heart rate \< 120 beats / min ; * 90 \< systolic blood pressure \< 200mmHg ; * 55 \< mean arterial pressure \< 120mmHg; * do not increase the dose of pressor drugs for at least 2 hours; * intracranial pressure is stable and there are no seizures within 24 hours; * the respiratory state is stable; * the patient's finger pulse oxygen saturation ≥ 88%; * 10 \< respiratory frequency \< 35 beats / min. Exclusion Criteria: * Pregnancy; * acute cardio-cerebrovascular events; * spinal or limb fractures; * active bleeding.
Contact & Investigator
wang, doctor
PRINCIPAL INVESTIGATOR
The First Medical Center of PLA General Hospital
Frequently Asked Questions
Who can join the NCT04441151 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04441151 currently recruiting?
Yes, NCT04441151 is actively recruiting participants. Contact the research team at zhaoying301301@163.com for enrollment information.
Where is the NCT04441151 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT04441151 clinical trial?
NCT04441151 is sponsored by Chinese PLA General Hospital. The principal investigator is wang, doctor at The First Medical Center of PLA General Hospital. The trial plans to enroll 70 participants.